by Laurie Fickman, University of Houston Visual abstract. Credit: JAMA Network Open (2023). DOI: 10.1001/jamanetworkopen.2022.53570 Kevin Garey, a professor of pharmacy practice and translational research at the University of Houston College of Pharmacy, is reporting the first well-controlled study to demonstrate that a microbiome therapeutic, SER-109, is associated with significant quality of life improvement in patients with the debilitating...
